Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...
Background Immunogenicity to SARS-CoV-2 vaccination in patients with SLE varies by vaccine type and immune-modulating therapy. However, data in Southeast Asian populations, especially among Thai ...
Hospital infection therapeutics market size was valued at US$ 10.5 billion in 2024 and is projected to hit the market valuation of US$ 14.7 billion by 2033 at a CAGR of 3.8% during the forecast period ...
In 2019, the global neutropenia treatment market was valued at a staggering $12,602.5 million. This figure encapsulates the substantial demand for innovative therapies aimed at combating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback